HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Halvatsiotis, P. Articles by Nair, K. S. Search for Related Content PubMed PubMed Citation Articles by Halvatsiotis, P. Articles by Nair, K. S. Social Bookmarking                What's this?

Synthesis Rate of Muscle Proteins, Muscle Functions, and Amino Acid Kinetics in Type 2 Diabetes

From the Division of Endocrinology, Mayo Clinic and Foundation, Rochester, Minnesota

Improvement of glycemic status by insulin is associated with profound changes in amino acid metabolism in type 1 diabetes. In contrast, a dissociation of insulin effect on glucose and amino acid metabolism has been reported in type 2 diabetes. Type 2 diabetic patients are reported to have reduced muscle oxidative enzymes and VO_2max. We investigated the effect of 11 days of intensive insulin treatment (T₂D+) on whole-body amino acid kinetics, muscle protein synthesis rates, and muscle functions in eight type 2 diabetic subjects after withdrawing all treatments for 2 weeks (T₂D-) and compared the results with those of weight-matched lean control subjects using stable isotopes of the amino acids. Whole-body leucine, phenylalanine and tyrosine fluxes, leucine oxidation, and plasma amino acid levels were similar in all groups, although plasma glucose levels were significantly higher in T₂D-. Insulin treatment reduced leucine nitrogen flux and transamination rates in subjects with type 2 diabetes. Synthesis rates of muscle mitochondrial, sarcoplasmic, and mixed muscle proteins were not affected by glycemic status or insulin treatment in subjects with type 2 diabetes. Muscle strength was also unaffected by diabetes or glycemic status. In contrast, the diabetic patients showed increased tendency for muscle fatigability. Insulin treatment also failed to stimulate muscle cytochrome C oxidase activity in the diabetic patients, although it modestly elevated citrate synthase. In conclusion, improvement of glycemic status by insulin treatment did not alter whole-body amino acid turnover in type 2 diabetic subjects, but leucine nitrogen flux, transamination rates, and plasma ketoisocaproate level were decreased. Insulin treatments in subjects with type 2 diabetes had no effect on muscle mitochondrial protein synthesis and cytochrome C oxidase, a key enzyme for ATP production.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				N. Moller and K. S. Nair Diabetes and Protein Metabolism Diabetes, January 1, 2008; 57(1): 3 - 4. [Full Text] [PDF]

				S. Pereira, E. B. Marliss, J. A. Morais, S. Chevalier, and R. Gougeon Insulin Resistance of Protein Metabolism in Type 2 Diabetes Diabetes, January 1, 2008; 57(1): 56 - 63. [Abstract] [Full Text] [PDF]

				M. G. Burt, J. Gibney, and K. K. Y. Ho Protein metabolism in glucocorticoid excess: study in Cushing's syndrome and the effect of treatment Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1426 - E1432. [Abstract] [Full Text] [PDF]

				A. P. W. Johnston, J. E. Campbell, J. G. Found, M. C. Riddell, and T. J. Hawke Streptozotocin induces G2 arrest in skeletal muscle myoblasts and impairs muscle growth in vivo Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1033 - C1040. [Abstract] [Full Text] [PDF]

				Y. W. Asmann, C. S. Stump, K. R. Short, J. M. Coenen-Schimke, Z. Guo, M. L. Bigelow, and K. S. Nair Skeletal Muscle Mitochondrial Functions, Mitochondrial DNA Copy Numbers, and Gene Transcript Profiles in Type 2 Diabetic and Nondiabetic Subjects at Equal Levels of Low or High Insulin and Euglycemia Diabetes, December 1, 2006; 55(12): 3309 - 3319. [Abstract] [Full Text] [PDF]

				S. Salinari, A. Bertuzzi, A. Gandolfi, A. V. Greco, A. Scarfone, M. Manco, and G. Mingrone Dodecanedioic acid overcomes metabolic inflexibility in type 2 diabetic subjects Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1051 - E1058. [Abstract] [Full Text] [PDF]

				D. N. Reeds, W. T. Cade, B. W. Patterson, W. G. Powderly, S. Klein, and K. E. Yarasheski Whole-Body Proteolysis Rate Is Elevated in HIV-Associated Insulin Resistance. Diabetes, October 1, 2006; 55(10): 2849 - 2855. [Abstract] [Full Text] [PDF]

				X. Wang, Z. Hu, J. Hu, J. Du, and W. E. Mitch Insulin Resistance Accelerates Muscle Protein Degradation: Activation of the Ubiquitin-Proteasome Pathway by Defects in Muscle Cell Signaling Endocrinology, September 1, 2006; 147(9): 4160 - 4168. [Abstract] [Full Text] [PDF]

				J. A. Bell, E. Volpi, S. Fujita, J. G. Cadenas, M. Sheffield-Moore, and B. B. Rasmussen Skeletal Muscle Protein Anabolic Response to Increased Energy and Insulin Is Preserved in Poorly Controlled Type 2 Diabetes J. Nutr., May 1, 2006; 136(5): 1249 - 1255. [Abstract] [Full Text] [PDF]

				L. Tian, S. A. Greenberg, S. W. Kong, J. Altschuler, I. S. Kohane, and P. J. Park Discovering statistically significant pathways in expression profiling studies PNAS, September 20, 2005; 102(38): 13544 - 13549. [Abstract] [Full Text] [PDF]

				A. Jaleel, P. Halvatsiotis, B. Williamson, P. Juhasz, S. Martin, and K. S. Nair Identification of Amadori-Modified Plasma Proteins in Type 2 Diabetes and the Effect of Short-Term Intensive Insulin Treatment Diabetes Care, March 1, 2005; 28(3): 645 - 652. [Abstract] [Full Text] [PDF]

				S. Murakami, T. Sasaoka, T. Wada, K. Fukui, K. Nagira, H. Ishihara, I. Usui, and M. Kobayashi Impact of Src Homology 2-Containing Inositol 5'-Phosphatase 2 on the Regulation of Insulin Signaling Leading to Protein Synthesis in 3T3-L1 Adipocytes Cultured with Excess Amino Acids Endocrinology, July 1, 2004; 145(7): 3215 - 3223. [Abstract] [Full Text] [PDF]

				K. R. Short, K. S. Nair, C. S. Stump, M. Bajaj, L. J. Mandarino, P. J. Raubenheimer, M. Mohlig, F. Isken, M. Ristow, K. F. Petersen, et al. Impaired Mitochondrial Activity and Insulin-Resistant Offspring of Patients with Type 2 Diabetes N. Engl. J. Med., June 3, 2004; 350(23): 2419 - 2421. [Full Text] [PDF]

				K. S. Nair, A. Jaleel, Y. W. Asmann, K. R. Short, and S. Raghavakaimal Proteomic research: potential opportunities for clinical and physiological investigators Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E863 - E874. [Abstract] [Full Text] [PDF]

				M. Aragno, R. Mastrocola, M. G. Catalano, E. Brignardello, O. Danni, and G. Boccuzzi Oxidative Stress Impairs Skeletal Muscle Repair in Diabetic Rats Diabetes, April 1, 2004; 53(4): 1082 - 1088. [Abstract] [Full Text] [PDF]

				R. Barazzoni, E. Kiwanuka, M. Zanetti, M. Cristini, M. Vettore, and P. Tessari Insulin Acutely Increases Fibrinogen Production in Individuals With Type 2 Diabetes but Not in Individuals Without Diabetes Diabetes, July 1, 2003; 52(7): 1851 - 1856. [Abstract] [Full Text] [PDF]

				C. S. Stump, K. R. Short, M. L. Bigelow, J. M. Schimke, and K. S. Nair Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts PNAS, June 24, 2003; 100(13): 7996 - 8001. [Abstract] [Full Text] [PDF]